Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis.
about
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamineEffects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialMacrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
P2860
Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@en
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@nl
type
label
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@en
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@nl
prefLabel
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@en
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Impact of MMX® mesalamine on i ...... ients with ulcerative colitis.
@en
P2093
Dory Solomon
Linnette Yen
Paul Hodgkins
Robyn Karlstadt
Sunanda Kane
P2860
P304
P356
10.1002/IBD.23022
P50
P577
2013-02-01T00:00:00Z